ICD-O coding of thoracic tumours 
ICD-O topographical coding of thoracic tumours
The ICD-O topography codes for the main anatomical sites covered in this volume are as follows [[Fritz A, Percy C, Jack A, et al., editors. International classification of diseases for oncology (ICD-O). 3rd ed. 1st rev. Geneva (Switzerland): World Health Organization; 2013.]]:

 

C33 Trachea

      C33.9 Trachea

 

C34 Bronchus and lung

      C34.0 Main bronchus

      C34.1 Upper lobe, lung

      C34.2 Middle lobe, lung

      C34.3 Lower lobe, lung

      C34.8 Overlapping lesion of lung

      C34.9 Lung NOS

 

C37 Thymus

      C37.9 Thymus

 

C38 Heart, mediastinum, and pleura

      C38.0 Heart

      C38.1 Anterior mediastinum

      C38.2 Posterior mediastinum

      C38.3 Mediastinum NOS

      C38.4 Pleura NOS

      C38.8 Overlapping lesion of heart, mediastinum, and pleura

 

C39 Other and ill-defined sites within respiratory system and intrathoracic organs

      C39.0 Upper respiratory tract NOS

      C39.8 Overlapping lesion of respiratory system and intrathoracic organs

      C39.9 Ill-defined sites within respiratory system

 

C76 Other and ill-defined sites

      C76.1 Thorax NOS

 

C77 Lymph nodes

      C77.1 Intrathoracic lymph nodes

 

 

ICD-O morphological coding: Introduction
The ICD-O coding system uses a topography (T) code and a morphology (M) code together, but these are presented in separate lists for ease of use. Behaviour is coded /0 for benign tumours; /1 for unspecified, borderline, or uncertain behaviour; /2 for carcinoma in situ and grade III intraepithelial neoplasia; /3 for malignant tumours, primary site; and /6 for malignant tumours, metastatic site. Behaviour code /6 is not generally used by cancer registries. For various reasons, the ICD-O morphology terms may not always be identical to the entity names used in the WHO classification, but they should be sufficiently similar to avoid confusion. The designation “NOS” (“not otherwise specified”) is provided to make coding possible when subtypes exist but exact classification may not be possible in small biopsies or certain other scenarios. Therefore, it is usual to have “NOS” even when a more specific alternative term is listed in ICD-O. 

 

ICD-O coding of tumours of the lung
Epithelial tumours

Papillomas

8052/0 Squamous cell papilloma, NOS

8053/0 Squamous cell papilloma, inverted

8260/0 Glandular papilloma

8560/0 Mixed squamous cell and glandular papilloma

 

Adenomas

8832/0 Sclerosing pneumocytoma

8251/0 Alveolar adenoma

8260/0 Papillary adenoma

8140/0 Bronchiolar adenoma / ciliated muconodular papillary tumour†

8470/0 Mucinous cystadenoma

8480/0 Mucous gland adenoma

 

Precursor glandular lesions

8250/0 Atypical adenomatous hyperplasia

Adenocarcinoma in situ

      8250/2 Adenocarcinoma in situ, non-mucinous

      8253/2 Adenocarcinoma in situ, mucinous

 

Adenocarcinomas

Minimally invasive adenocarcinoma

      8256/3 Minimally invasive adenocarcinoma, non-mucinous

      8257/3 Minimally invasive adenocarcinoma, mucinous

Invasive non-mucinous adenocarcinoma

      8250/3 Lepidic adenocarcinoma

      8551/3 Acinar adenocarcinoma

      8260/3 Papillary adenocarcinoma

      8265/3 Micropapillary adenocarcinoma

      8230/3 Solid adenocarcinoma

8253/3 Invasive mucinous adenocarcinoma

      8254/3 Mixed invasive mucinous and non-mucinous adenocarcinoma

8480/3 Colloid adenocarcinoma

8333/3 Fetal adenocarcinoma

8144/3 Adenocarcinoma, enteric-type

8140/3 Adenocarcinoma, NOS

 

Squamous precursor lesions

8070/2 Squamous cell carcinoma in situ

8077/0 Mild squamous dysplasia

8077/2 Moderate squamous dysplasia

8077/2 Severe squamous dysplasia

 

Squamous cell carcinomas

8070/3 Squamous cell carcinoma, NOS

      8071/3 Squamous cell carcinoma, keratinizing

      8072/3 Squamous cell carcinoma, non-keratinizing

      8083/3 Basaloid squamous cell carcinoma

8082/3 Lymphoepithelial carcinoma

 

Large cell carcinomas

8012/3 Large cell carcinoma

 

Adenosquamous carcinomas

8560/3 Adenosquamous carcinoma

 

Sarcomatoid carcinomas

8022/3 Pleomorphic carcinoma

      8031/3 Giant cell carcinoma

      8032/3 Spindle cell carcinoma

8972/3 Pulmonary blastoma

8980/3 Carcinosarcoma

 

Other epithelial tumours

8023/3 NUT carcinoma

8044/3 Thoracic SMARCA4-deficient undifferentiated tumour†

 

Salivary gland–type tumours

8940/0 Pleomorphic adenoma

8200/3 Adenoid cystic carcinoma

8562/3 Epithelial-myoepithelial carcinoma

8430/3 Mucoepidermoid carcinoma

8310/3 Hyalinizing clear cell carcinoma†

8982/0 Myoepithelioma

8982/3 Myoepithelial carcinoma

 

Lung neuroendocrine neoplasms

Precursor lesion

8040/0 Diffuse idiopathic neuroendocrine cell hyperplasia

 

Neuroendocrine tumours

8240/3 Carcinoid tumour, NOS / neuroendocrine tumour, NOS

      8240/3 Typical carcinoid / neuroendocrine tumour, grade 1

      8249/3 Atypical carcinoid / neuroendocrine tumour, grade 2

 

Neuroendocrine carcinomas

8041/3 Small cell carcinoma

      8045/3 Combined small cell carcinoma

8013/3 Large cell neuroendocrine carcinoma

      8013/3 Combined large cell neuroendocrine carcinoma

 

Tumours of ectopic tissues

8720/3 Melanoma

9530/0 Meningioma

 

Mesenchymal tumours specific to the lung

8992/0 Pulmonary hamartoma

9220/0 Chondroma

9170/3 Diffuse lymphangiomatosis†

8973/3 Pleuropulmonary blastoma

9137/3 Intimal sarcoma

8827/1 Congenital peribronchial myofibroblastic tumour

8842/3 Pulmonary myxoid sarcoma with EWSR1-CREB1 fusion

 

PEComatous tumours

9174/3* Lymphangioleiomyomatosis

8714/0 PEComa, benign

8714/3 PEComa, malignant

 

Haematolymphoid tumours

9699/3 MALT lymphoma

9680/3 Diffuse large B-cell lymphoma, NOS

9766/1 Lymphomatoid granulomatosis, NOS

      9766/1 Lymphomatoid granulomatosis, grade 1

      9766/1 Lymphomatoid granulomatosis, grade 2

      9766/3 Lymphomatoid granulomatosis, grade 3

9712/3 Intravascular large B-cell lymphoma

9751/1 Langerhans cell histiocytosis

9749/3 Erdheim–Chester disease

 

 

ICD-O coding of tumours of the pleura and pericardium
Mesothelial tumours

Benign and preinvasive mesothelial tumours

9054/0 Adenomatoid tumour

9052/1 Well-differentiated papillary mesothelial tumour†

9050/2* Mesothelioma in situ

 

Mesothelioma

9050/3 Localized mesothelioma†

9050/3 Diffuse mesothelioma, NOS†

      9051/3 Sarcomatoid mesothelioma

      9052/3 Epithelioid mesothelioma

      9053/3 Mesothelioma, biphasic

 

Haematolymphoid tumours

9678/3 Primary effusion lymphoma

9680/3 Diffuse large B-cell lymphoma associated with chronic inflammation

 

 

ICD-O coding of tumours of the heart
Benign tumours

8820/0 Papillary fibroelastoma†

8840/0 Myxoma, NOS

8810/0 Fibroma, NOS

8900/0 Rhabdomyoma, NOS

8904/0 Adult cellular rhabdomyoma

8850/0 Lipoma, NOS

Lipomatous hamartoma of atrioventricular valve

Hamartoma of mature cardiac myocytes

Mesenchymal cardiac hamartoma

9120/0 Haemangioma, NOS

9122/0 Venous haemangioma

9131/0 Capillary haemangioma

9123/0 Arteriovenous haemangioma

9121/0 Cavernous haemangioma

Conduction system hamartoma

8454/0 Cystic tumour of atrioventricular node

 

Malignant tumours

9120/3 Angiosarcoma

8890/3 Leiomyosarcoma, NOS

8802/3 Pleomorphic sarcoma

 

Haematolymphoid tumours

9680/3 Diffuse large B-cell lymphoma, NOS

9680/3 Fibrin-associated diffuse large B-cell lymphoma†

 

 

ICD-O coding of mesenchymal tumours of the thorax
Adipocytic tumours

8850/0 Lipoma, NOS

8850/0 Thymolipoma

8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated

8852/3 Myxoid liposarcoma

8854/3 Pleomorphic liposarcoma

8858/3 Dedifferentiated liposarcoma

 

Fibroblastic and myofibroblastic tumours

8821/1 Desmoid-type fibromatosis

8815/1 Solitary fibrous tumour, NOS

8817/0 Calcifying fibrous tumour

8825/1 Inflammatory myofibroblastic tumour

8811/3 Myxofibrosarcoma

 

Vascular tumours

9120/0 Haemangioma, NOS

9121/0 Cavernous haemangioma

9122/0 Venous haemangioma

9132/0 Intramuscular haemangioma

9123/0 Arteriovenous haemangioma

9170/0 Lymphangioma, NOS

9173/0 Cystic lymphangioma

9133/3 Epithelioid haemangioendothelioma

9120/3 Angiosarcoma

 

Skeletal muscle tumours

8900/3 Rhabdomyosarcoma, NOS

8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

8920/3 Alveolar rhabdomyosarcoma

8901/3 Pleomorphic rhabdomyosarcoma

 

Peripheral nerve sheath and neural tumours

8693/3 Extra-adrenal paraganglioma

9580/0 Granular cell tumour

9580/3 Granular cell tumour, malignant

9560/0 Schwannoma

9540/3 Malignant peripheral nerve sheath tumour

9490/0 Ganglioneuroma

9490/3 Ganglioneuroblastoma

9500/3 Neuroblastoma

 

Tumours of uncertain differentiation

9040/3 Synovial sarcoma, NOS

      9041/3 Synovial sarcoma, spindle cell

      9042/3 Synovial sarcoma, epithelioid cell

      9043/3 Synovial sarcoma, biphasic

9364/3 Ewing sarcoma

9367/3* CIC-rearranged sarcoma

9368/3* Sarcoma with BCOR genetic alterations

9366/3* Round cell sarcoma with EWSR1–non-ETS fusions

 

 

ICD-O coding of tumours of the thymus
Epithelial tumours

Thymomas

8580/3 Thymoma, NOS

8581/3 Thymoma, type A

8582/3 Thymoma, type AB

8583/3 Thymoma, type B1

8584/3 Thymoma, type B2

8585/3 Thymoma, type B3

8580/1 Micronodular thymoma with lymphoid stroma

8580/3 Metaplastic thymoma

9010/0 Lipofibroadenoma

 

Squamous carcinomas

8070/3 Squamous cell carcinoma, NOS

8123/3 Basaloid carcinoma

8082/3 Lymphoepithelial carcinoma

 

Adenocarcinomas

8140/3 Adenocarcinoma, NOS

8260/3 Low-grade papillary adenocarcinoma†

8200/3 Thymic carcinoma with adenoid cystic carcinoma–like features

8144/3 Adenocarcinoma, enteric-type

 

Adenosquamous carcinomas

8560/3 Adenosquamous carcinoma

 

NUT carcinomas

8023/3 NUT carcinoma

 

Salivary gland–like carcinomas

8430/3 Mucoepidermoid carcinoma

8310/3 Clear cell carcinoma

8033/3 Sarcomatoid carcinoma

8980/3 Carcinosarcoma

 

Undifferentiated carcinomas

8020/3 Carcinoma, undifferentiated, NOS

 

Thymic carcinomas

8586/3 Thymic carcinoma, NOS

 

Thymic neuroendocrine neoplasms

Neuroendocrine tumours

8240/3 Carcinoid tumour, NOS / neuroendocrine tumour, NOS

      8240/3 Typical carcinoid / neuroendocrine tumour, grade 1

      8249/3 Atypical carcinoid / neuroendocrine tumour, grade 2

 

Neuroendocrine carcinomas

8041/3 Small cell carcinoma

      8045/3 Combined small cell carcinoma

8013/3 Large cell neuroendocrine carcinoma

 

 

ICD-O coding of germ cell tumours of the mediastinum
9061/3 Seminoma

9070/3 Embryonal carcinoma

9071/3 Yolk sac tumour

9100/3 Choriocarcinoma

9080/0 Mature teratoma

9080/1 Immature teratoma of the thymus

9085/3 Mixed germ cell tumour

9084/3 Teratoma with somatic-type malignancies

9086/3 Germ cell tumour with associated haematological malignancy

 

 

ICD-O coding of haematolymphoid tumours of the mediastinum
9679/3 Mediastinal large B-cell lymphoma

9699/3 MALT lymphoma

9837/3 T-lymphoblastic leukaemia/lymphoma

9650/3 Classic Hodgkin lymphoma, NOS†

      9663/3 Classic Hodgkin lymphoma, nodular sclerosis

      9652/3 Classic Hodgkin lymphoma, mixed cellularity

      9651/3 Classic Hodgkin lymphoma, lymphocyte-rich

      9653/3 Classic Hodgkin lymphoma, lymphocyte depletion

9596/3 Grey zone lymphoma†

9758/3 Follicular dendritic cell sarcoma

9930/3 Myeloid sarcoma

 

 

ICD-O coding of ectopic tumours of thyroid and parathyroid origin
Thyroid neoplasms

8260/3 Papillary carcinoma of thyroid

8330/0 Follicular adenoma

8330/3 Follicular carcinoma

8345/3 Medullary thyroid carcinoma

 

Parathyroid neoplasms

8140/0 Parathyroid adenoma

8140/3 Parathyroid carcinom

 

Notes
These morphology codes are from the International Classification of Diseases for Oncology, third edition, second revision (ICD-O-3.2) [[International Association of Cancer Registries (IACR) [Internet]. Lyon (France): International Agency for Research on Cancer; 2019. ICD-O-3.2; updated 2019 Apr 23. Available from: http://www.iacr.com.fr/index.php?option=com_content&view=article&id=149:icd-o-3-2&catid=80&Itemid=545.]]. Behaviour is coded /0 for benign tumours; /1 for unspecified, borderline, or uncertain behaviour; /2 for carcinoma in situ and grade III intraepithelial neoplasia; /3 for malignant tumours, primary site; and /6 for malignant tumours, metastatic site. Behaviour code /6 is not generally used by cancer registries.

This classification is modified from the previous WHO classification, taking into account changes in our understanding of these lesions.

Subtype labels are indented.

* Codes marked with an asterisk were approved by the IARC/WHO Committee for ICD-O at its meeting in October 2020.

† Labels marked with a dagger have undergone a change in terminology of a previous code.

 
